484 related articles for article (PubMed ID: 25650940)
1. Alzheimer's protective A2T mutation changes the conformational landscape of the Aβ₁₋₄₂ monomer differently than does the A2V mutation.
Das P; Murray B; Belfort G
Biophys J; 2015 Feb; 108(3):738-47. PubMed ID: 25650940
[TBL] [Abstract][Full Text] [Related]
2. Amyloid β-Protein Assembly: Differential Effects of the Protective A2T Mutation and Recessive A2V Familial Alzheimer's Disease Mutation.
Zheng X; Liu D; Roychaudhuri R; Teplow DB; Bowers MT
ACS Chem Neurosci; 2015 Oct; 6(10):1732-40. PubMed ID: 26244608
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's Protective Cross-Interaction between Wild-Type and A2T Variants Alters Aβ
Das P; Chacko AR; Belfort G
ACS Chem Neurosci; 2017 Mar; 8(3):606-618. PubMed ID: 28292185
[TBL] [Abstract][Full Text] [Related]
4. Dimerization Mechanism of Alzheimer Aβ
Nguyen PH; Sterpone F; Pouplana R; Derreumaux P; Campanera JM
J Phys Chem B; 2016 Dec; 120(47):12111-12126. PubMed ID: 27933940
[TBL] [Abstract][Full Text] [Related]
5. A2T and A2V Aβ peptides exhibit different aggregation kinetics, primary nucleation, morphology, structure, and LTP inhibition.
Murray B; Sorci M; Rosenthal J; Lippens J; Isaacson D; Das P; Fabris D; Li S; Belfort G
Proteins; 2016 Apr; 84(4):488-500. PubMed ID: 26799157
[TBL] [Abstract][Full Text] [Related]
6. Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors.
Chakraborty S; Das P
Sci Rep; 2017 Aug; 7(1):9941. PubMed ID: 28855598
[TBL] [Abstract][Full Text] [Related]
7. Weaker N-Terminal Interactions for the Protective over the Causative Aβ Peptide Dimer Mutants.
Sharma B; Ranganathan SV; Belfort G
ACS Chem Neurosci; 2018 Jun; 9(6):1247-1253. PubMed ID: 29465978
[TBL] [Abstract][Full Text] [Related]
8. Modulation in the conformational and stability attributes of the Alzheimer's disease associated amyloid-beta mutants and their favorable stabilization by curcumin: molecular dynamics simulation analysis.
Awasthi M; Singh S; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2018 Feb; 36(2):407-422. PubMed ID: 28054501
[TBL] [Abstract][Full Text] [Related]
9. Impact of the A2V Mutation on the Heterozygous and Homozygous Aβ1-40 Dimer Structures from Atomistic Simulations.
Nguyen PH; Sterpone F; Campanera JM; Nasica-Labouze J; Derreumaux P
ACS Chem Neurosci; 2016 Jun; 7(6):823-32. PubMed ID: 27007027
[TBL] [Abstract][Full Text] [Related]
10. The Pathogenic A2V Mutant Exhibits Distinct Aggregation Kinetics, Metal Site Structure, and Metal Exchange of the Cu
Somavarapu AK; Shen F; Teilum K; Zhang J; Mossin S; Thulstrup PW; Bjerrum MJ; Tiwari MK; Szunyogh D; Søtofte PM; Kepp KP; Hemmingsen L
Chemistry; 2017 Oct; 23(55):13591-13595. PubMed ID: 28815875
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's amyloid-β A2T variant and its N-terminal peptides inhibit amyloid-β fibrillization and rescue the induced cytotoxicity.
Lin TW; Chang CF; Chang YJ; Liao YH; Yu HM; Chen YR
PLoS One; 2017; 12(3):e0174561. PubMed ID: 28362827
[TBL] [Abstract][Full Text] [Related]
12. The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.
Benilova I; Gallardo R; Ungureanu AA; Castillo Cano V; Snellinx A; Ramakers M; Bartic C; Rousseau F; Schymkowitz J; De Strooper B
J Biol Chem; 2014 Nov; 289(45):30977-89. PubMed ID: 25253695
[TBL] [Abstract][Full Text] [Related]
13. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
Xu L; Chen Y; Wang X
Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
[TBL] [Abstract][Full Text] [Related]
14. Familial Alzheimer A2 V mutation reduces the intrinsic disorder and completely changes the free energy landscape of the Aβ1-28 monomer.
Nguyen PH; Tarus B; Derreumaux P
J Phys Chem B; 2014 Jan; 118(2):501-10. PubMed ID: 24372615
[TBL] [Abstract][Full Text] [Related]
15. Structures and free-energy landscapes of the wild type and mutants of the Abeta(21-30) peptide are determined by an interplay between intrapeptide electrostatic and hydrophobic interactions.
Tarus B; Straub JE; Thirumalai D
J Mol Biol; 2008 Jun; 379(4):815-29. PubMed ID: 18479708
[TBL] [Abstract][Full Text] [Related]
16. Aβ monomers transiently sample oligomer and fibril-like configurations: ensemble characterization using a combined MD/NMR approach.
Rosenman DJ; Connors CR; Chen W; Wang C; García AE
J Mol Biol; 2013 Sep; 425(18):3338-59. PubMed ID: 23811057
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic Aβ A2V versus protective Aβ A2T mutation: Early stage aggregation and membrane interaction.
Colombo L; Gamba A; Cantù L; Salmona M; Tagliavini F; Rondelli V; Del Favero E; Brocca P
Biophys Chem; 2017 Oct; 229():11-18. PubMed ID: 28502484
[TBL] [Abstract][Full Text] [Related]
18. Impact of A2V Mutation and Histidine Tautomerism on Aβ42 Monomer Structures from Atomistic Simulations.
Li H; Nam Y; Salimi A; Lee JY
J Chem Inf Model; 2020 Jul; 60(7):3587-3592. PubMed ID: 32551634
[TBL] [Abstract][Full Text] [Related]
19. Effect of Alzheimer's Disease Causative and Protective Mutations on the Hydration Environment of Amyloid-β.
Aggarwal L; Biswas P
J Phys Chem B; 2020 Mar; 124(12):2311-2322. PubMed ID: 32130011
[TBL] [Abstract][Full Text] [Related]
20. Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer.
Lin YS; Bowman GR; Beauchamp KA; Pande VS
Biophys J; 2012 Jan; 102(2):315-24. PubMed ID: 22339868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
